痛风发病年龄特征及降尿酸治疗对内皮功能的影响(4)
[16]Sharaf El Din UAA，Salem MM，Abdulazim DO.Uric acid in the pathogenesis of metabolic，renal，and cardiovascular diseases：A review[J]. J Adv Res，2017，8(5)：537-548.
[17]Alshahawey M，Shahin SM，Elsaid TW，et al. Effect of febuxostat on the endothelial dysfunction in hemodialysis patients：A randomized，placebo-controlled，double-blinded study[J].Am J Nephrol，2017，45(5)：452-459.
[18]Tausche AK，Christoph M，Forkmann M，et al.As compared to allopurinol， urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout[J].Rheumatol Int，2014，34(1)：101-109.
[19]Kojima S，Matsui K，Ogawa H，et al.Rationale，design， and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral， cardiovascular，and renal events in patients with hyperuricemia[J].J Cardiol，2017，69(1)：169-175.
[20]陶小軍，金星，陶沙，等.不同剂量非布司他对痛风伴高尿酸血症的效果及对内皮素-1 水平的影响[J].中国全科医学，2014，17(2)：170-172.
(收稿日期：2017-07-22), 百拇医药(许瑜佳 陈士芳)
[17]Alshahawey M，Shahin SM，Elsaid TW，et al. Effect of febuxostat on the endothelial dysfunction in hemodialysis patients：A randomized，placebo-controlled，double-blinded study[J].Am J Nephrol，2017，45(5)：452-459.
[18]Tausche AK，Christoph M，Forkmann M，et al.As compared to allopurinol， urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout[J].Rheumatol Int，2014，34(1)：101-109.
[19]Kojima S，Matsui K，Ogawa H，et al.Rationale，design， and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral， cardiovascular，and renal events in patients with hyperuricemia[J].J Cardiol，2017，69(1)：169-175.
[20]陶小軍，金星，陶沙，等.不同剂量非布司他对痛风伴高尿酸血症的效果及对内皮素-1 水平的影响[J].中国全科医学，2014，17(2)：170-172.
(收稿日期：2017-07-22), 百拇医药(许瑜佳 陈士芳)